Perlegen Sciences, Inc.'s Contribution to Phase 2 HapMap of Human Genetic Variation Empowers Scientists Studying Common Diseases

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--The six-country International HapMap Consortium today made available to the public its second-generation map of human genetic variation. This new map contains three times the number of markers unveiled in the initial version, released in 2005. The Consortium noted that this unprecedented research tool “relied heavily on the high-throughput genotyping capacity of Perlegen Sciences, Inc., of Mountain View, Calif. The firm tested virtually the entire known catalog of human SNP [Single Nucleotide Polymorphism] variation on the HapMap samples, as well as contributed some of its own resources to make the map possible.”

MORE ON THIS TOPIC